Data Integrity Problems Continued to Surface in Recent Warning Letters
This article was originally published in The Gold Sheet
Recent GMP warning letters featured data integrity issues.
You may also be interested in...
Pharmaceutical manufacturers should use only heat-treated wooden pallets to ensure that they don’t have TBP-taints that can cause musty and moldy odors in plastic medicine bottles. There have been eight drug recall incidents since 2009 for smells emanating from TBP.
How contamination, sterility assurance, OOS and other issues caused drug recalls to spike again last year. What happened at Aidapak, H&P, Ben Venue, Hospira, Teva and other manufacturers to set a new record.
FDA hits heparin supply chain; Ranbaxy consents to data integrity oversight; multinationals find solutions to China’s vaccine compendial crisis; EU seeks comment on safety measures, API imports.